Translational Session

Genetic Correlations of Renal Biopsy Findings, Including the Robert W. Schrier, MD, Endowed Lectureship

November 08, 2019 | 10:30 AM - 12:30 PM

Location: 147, Walter E. Washington Convention Center

Session Description

In some situations, renal biopsy provides a diagnosis that is incomplete and requires additional genetic studies; sometimes, genetic studies produce results that may seem to conflict with biopsy findings. This session focuses on the interplay of histology and genetic analysis, with particular focus on whole-exome sequencing in CKD, genetic findings in ESKD of unknown origin, the expanding spectrum of collagen IV diseases, the clinical impact of APOL1 testing, and genetic testing in atypical hemolytic uremic syndrome.

ASN gratefully acknowledges Otsuka America Pharmaceutical, Novartis, Astellas Pharma US, and several individuals for support of the Robert W. Schrier, MD, Endowed Lectureship.

Learning Objective(s)

  • Describe the role of genetic testing in the management of patients with renal disease
  • Identify renal biopsy findings that require genetic analysis
  • Explain how the interplay of renal biopsy findings and genetic analysis can affect treatment and prognosis

Learning Pathway(s)

  • Genetic Diseases of the Kidneys
  • Pathology

Moderators

  • Joseph Gaut, MD, PhD
  • Matt G. Sampson, MD

Presentations